TY - JOUR
T1 - Probes of ubiquitin E3 ligases enable systematic dissection of parkin activation
AU - Pao, Kuan Chuan
AU - Stanley, Mathew
AU - Han, Cong
AU - Lai, Yu Chiang
AU - Murphy, Paul
AU - Balk, Kristin
AU - Wood, Nicola T.
AU - Corti, Olga
AU - Corvol, Jean Christophe
AU - Muqit, Miratul M.K.
AU - Virdee, Satpal
PY - 2016/3/7
Y1 - 2016/3/7
N2 - E3 ligases represent an important class of enzymes, yet there are currently no chemical probes for profiling their activity. We develop a new class of activity-based probe by re-engineering a ubiquitin-charged E2 conjugating enzyme and demonstrate the utility of these probes by profiling the transthiolation activity of the RING-in-between-RING (RBR) E3 ligase parkin in vitro and in cellular extracts. Our study provides valuable insight into the roles, and cellular hierarchy, of distinct phosphorylation events in parkin activation. We also profile parkin mutations associated with patients with Parkinson's disease and demonstrate that they mediate their effect largely by altering transthiolation activity. Furthermore, our probes enable direct and quantitative measurement of endogenous parkin activity, revealing that endogenous parkin is activated in neuronal cell lines (≥75%) in response to mitochondrial depolarization. This new technology also holds promise as a novel biomarker of PINK1-parkin signaling, as demonstrated by its compatibility with samples derived from individuals with Parkinson's disease.
AB - E3 ligases represent an important class of enzymes, yet there are currently no chemical probes for profiling their activity. We develop a new class of activity-based probe by re-engineering a ubiquitin-charged E2 conjugating enzyme and demonstrate the utility of these probes by profiling the transthiolation activity of the RING-in-between-RING (RBR) E3 ligase parkin in vitro and in cellular extracts. Our study provides valuable insight into the roles, and cellular hierarchy, of distinct phosphorylation events in parkin activation. We also profile parkin mutations associated with patients with Parkinson's disease and demonstrate that they mediate their effect largely by altering transthiolation activity. Furthermore, our probes enable direct and quantitative measurement of endogenous parkin activity, revealing that endogenous parkin is activated in neuronal cell lines (≥75%) in response to mitochondrial depolarization. This new technology also holds promise as a novel biomarker of PINK1-parkin signaling, as demonstrated by its compatibility with samples derived from individuals with Parkinson's disease.
UR - http://www.scopus.com/inward/record.url?scp=84959192267&partnerID=8YFLogxK
U2 - 10.1038/nchembio.2045
DO - 10.1038/nchembio.2045
M3 - Article
C2 - 26928937
AN - SCOPUS:84959192267
SN - 1552-4450
VL - 12
SP - 324
EP - 331
JO - Nature Chemical Biology
JF - Nature Chemical Biology
IS - 5
ER -